Results 101 to 110 of about 5,406 (200)

Netupitant versus aprepitant: model-predicted neurokinin-1 receptor occupancy and implications for long-delayed nausea and vomiting prevention. [PDF]

Support Care Cancer
Iihara H, Bianchini G, Aapro M, Licata L, Bernareggi A, Navari RM, Park YH, Jordan K, Vidal M, Scotté F, Roeland EJ, Schwartzberg L, Rugo HS.   +12 more
europepmc   +1 more source

Aprepitant, a Neurokinin-1 Receptor Antagonist, as a Disruptive Drug for the Treatment of Pediatric Cancer. [PDF]

J Clin Med
Rosso M, Alcaide C, Muñoz M.
europepmc   +1 more source

A pharmacoeconomic evaluation of aprepitant injection versus aprepitant capsules for the prevention of CINV caused by moderately and highly emetogenic chemotherapy. [PDF]

Front Pharmacol
Chen Z, Cai M, Dong Y, Jin L, Li M, Shen L, Jiang X.   +6 more
europepmc   +1 more source

Corrigendum to "D-pinitol modulates the anti-emetic effects of aprepitant, domperidone, and ondansetron in chicks" [Pharmaceut. Sci. Adv. 3, (2025), 100073]. [PDF]

Pharm Sci Adv
Rahman E, Rahman A, Sheikh S, Polash JI, Khatun S, Bristi SA, Akbor S, Haque F, Bappi MH, Tanim TI, Ansari SA, Ansari IA, Pereira Lucetti EC, Domiciano CB, Coutinho HDM, Islam MT.   +15 more
europepmc   +1 more source

Identification of Factors Associated With Clinically Problematic Hiccups in Male Patients Receiving Cisplatin-based Treatment With Dexamethasone and Aprepitant: A Subgroup Analysis. [PDF]

In Vivo
Saito Y, Takekuma Y, Sakakibara-Konishi J, Shimizu Y, Kinoshita I, Sugawara M.   +5 more
europepmc   +1 more source

Refractory nausea in an 86-year-old patient after surgery. [PDF]

CMAJ
Bhattacharjee A, Gruber A, MacMillan TE, Shah R.   +3 more
europepmc   +1 more source

Editorial Expression of Concern: Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation. [PDF]

BMC Cancer
Cao X, Yang Y, Zhou W, Wang Y, Wang X, Ge X, Wang F, Zhou F, Deng X, Miao L.   +9 more
europepmc   +1 more source

The substance P/ Neurokinin-1 receptor signaling drives perineural invasion in pancreatic ductal adenocarcinoma (PDAC). [PDF]

Front Cell Dev Biol
Schiedlauske K, Biskup S, Hofer L, Deipenbrock A, Çifcibaşı K, Demir IE, Esposito I, Weyhe D, Teusch NE.   +8 more
europepmc   +1 more source

Quantification of central substance P receptor occupancy by aprepitant using small animal positron emission tomography.

Central substance P receptors, termed NK-1 receptors, have been considered as therapeutic targets in the development of drugs against diverse conditions including emesis, overactive bladder and depression.
470095, Saijo, Takeaki, Maeda, Jun, 470105, 470104, 470107, Suhara, Tetsuya, 470106, Zhang, Ming-Rong, 470109, 470108, 張 明栄, 前田 純, Kannami, Ayako, Asai, Hidetoshi, 470101, 遠藤 忠, 470100, Endo, Tadashi, 470103, Tokunaga, Masaki, 470102, 樋口 真人, 須原 哲也, 西條 武明, Haneda, Eisuke, Higuchi, Makoto, Suzuki, Masayuki, 徳永 正希, 470097, 470096, 470099, 470110, 470098, 470112, 470111   +35 more
core  

Aprepitant and Fosaprepitant for Preventing Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy-A Real-World Study. [PDF]

Curr Oncol
Ünlü B, Demir H, Davarcı SE, Culha Y, Özaşkın D, Özkan FE, Yıldız S, Yıldız C, Baykara M.   +8 more
europepmc   +1 more source